AI biotech company Genesis scores $200M to advance drug discovery
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
Source: mobihealthnews.com
📰 Genentech News
Page 113 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
Genesis Therapeutics Closes Oversubscribed $200 Million Series B
Series B capital will be deployed to:Bring forward Genesis’ artificial intelligence-enabled pipeline into clinical developmentFurther advance Genesis’ field-leading physics-based AI platformAmbitiously expand Genesis’ pipeline, targeting the company’s AI platform against new high-value and previously undrugged targe...
Source: pharmiweb.com
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028
/PRNewswire/ -- DelveInsights Medical Second Opinion Market Insights report provides the current and forecast market analysis, individual leading medical...
Source: prnewswire.com
U.S. eyes battle with drug giants over 10 costly medications for seniors
One fast-moving lawsuit seeks to block the U.S. government from even starting the drug-price negotiation process.
Source: pressherald.com
Page A1 | Messenger-Inquirer E-Edition | messenger-inquirer.com
View the Messenger Inquirer for Saturday, August 19, 2023
Source: messenger-inquirer.com
U.S. eyes battle with drug giants over 10 costly medications for seniors on Medicare
The Biden administration is preparing to announce the first 10 medicines it will target under a program that allows the government to negotiate drug prices with pharmaceutical giants, part of a sweep...
Source: theday.com
Global AI in Clinical Trials Market Overview 2023-2035: AI
Dublin, Aug. 18, 2023 (GLOBE NEWSWIRE) -- The "AI in Clinical Trials Market: Software and Service Providers - Distribution by Trial Phase, Target...
New York United States United Kingdom Memorial Sloan Kettering Cancer Center Al Iskandariyah Cancer Institute
Source: globenewswire.com
Worse QOL Identified in Patients With Parkinson Disease With Depressed Caregivers
For patients with Parkinson disease, those whose caregivers have depression symptoms have worse quality of life and higher emergency department use.
United States University Of Pennsylvania Rudmila Rashid Perelman School Of Medicine Healthday News Perelman School
Source: neurologyadvisor.com
Global Lymphoproliferative Disorder Treatment Market Analysis (2019 - 2030)
Global Lymphoproliferative Disorder Treatment Market Analysis (2019 - 2030)
Source: pr-inside.com
U.S eyes battle with drug giants over 10 costly medications for seniors – Indianapolis Business Journal
The list is expected to arrive within the next two weeks, and industry experts believe it will include some of the most widely prescribed treatments for arthritis, blood disorders, heart disease and diabetes.
Source: ibj.com